PREPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER
乳腺癌术后生活的准备性干预措施
基本信息
- 批准号:8120897
- 负责人:
- 金额:$ 12.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAgeBiostatistics CoreBreast Cancer TreatmentCD-ROMCallbackCancer Information ServiceCancer PatientCaringClinicalCognitiveCollaborationsComputer softwareComputersControl GroupsCoping SkillsDataDevelopmentDistressDoseEducationEducational InterventionEffectiveness of InterventionsEnrollmentEthnic OriginGleanGoalsHealthHealth Services ResearchHigh Risk WomanInformal Social ControlInformation SpecialistsInternetInterventionLifeMalignant NeoplasmsMeasurementMediatingMediationMediator of activation proteinMedicalMental HealthMissionModelingMonitorMultimediaOutcomeParticipantPatientsPhasePrintingProcessProtocols documentationQuality ControlRaceRandomizedRecommendationRecording of previous eventsRecordsRecruitment ActivityRegional CancerRelative (related person)ReportingResearchRiskScienceSelf EfficacyServicesSpeedStress and CopingSurvivorsSystemTelephoneTelephone InterviewsTestingThinkingTimeTreatment EfficacyUnited StatesVisual AidWomanbasecancer recurrencechemotherapycopingcostdesigneffective interventionefficacy testingfollow-uphigh riskinformation processinginnovationintervention effectmalignant breast neoplasmpeerphysical conditioningprimary outcomeprogramsresponsesecondary outcomeservice interventionskillssocialsurvivorshiptheoriestherapy developmentvirtual
项目摘要
REPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER - Project 3
In the United States, over 2 million women live with a history of breast cancer. The re-entry transition from cancer patient
to survivor is an understudied and challenging period. Using a theory-driven conceptual framework, Project 3 of this
Cancer Information Service Research Consortium (CISRC) proposal involves development and testing of interventions to
promote informed re-entry to life after breast cancer treatment. The six primary aims are to: (1) develop and test a highly
innovative multimedia educational intervention'(CD-ROM, Internet), the Virtual Cancer Information Service (V-CIS); (2)
develop and test a telephone callback protocol conducted by the NCI's Cancer Information Service (CIS) Information
Specialists; (3) evaluate these interventions in randomized, 3-group stepped and 2-group designs, which, for those with
computer access, (a) Group 1=a control group] receiving standard CIS service and print material (NCI's Facing Forward
and What You Need To Know about Breast Cancer); (b) Group 2=standard care + V-CIS; (c) Group 3=standard care +
V-CIS + two CIS telephone callbacks; and, for those who lack computer access, (d) Group 1 A=control=same standard
print as Group 1; (e) Group 2A=standard print * 2 CIS intervention callbacks; (4) evaluate a theory-driven test of
mediators (i.e., self-efficacy, perceived coping skill) of intervention effects; (5) test putative moderators (e.g., participant
age) of intervention effects; (6) with the CIS, plan dissemination. To test the efficacy of the intervention, 1,800 breast
cancer callers to the CIS will be enrolled, and depending on computer access, randomized to the 3-group or the 2-group
design, and followed at 2, 6, and 12 months post-baseline. Conforming to a dose-response gradient, the primary
hypothesis is that Group 3 > Group 2 > Group i1 (and Group 2A > Group 1 A) with regard to positive outcomes in the
domains of psychological health, physical health, interpersonal functioning, and life perspectives. Hypotheses regarding
how (i.e., mediators) and for whom (i.e., moderators) the interventions are effective also will be examined. Project 3 is
unique in that it examines a state-of-the-science software program and proactive CIS-initiated telephone callbacks, thus
addressing the primary service mission of the CIS. Contingent upon findings, the goal of the CISRC is to prepare the
intervention for dissemination within the CIS, as well as other service programs nationwide.
乳腺癌术后生活的修复干预措施 - 项目 3
在美国,超过 200 万女性有乳腺癌病史。癌症患者的再入境转变
对于幸存者来说,这是一个未被充分研究且充满挑战的时期。使用理论驱动的概念框架,本项目的项目 3
癌症信息服务研究联盟 (CISRC) 提案涉及干预措施的开发和测试
促进乳腺癌治疗后知情地重返生活。六个主要目标是:(1)开发和测试高度
创新的多媒体教育干预(CD-ROM、互联网)、虚拟癌症信息服务(V-CIS); (2)
开发并测试由 NCI 癌症信息服务 (CIS) 执行的电话回拨协议
专家; (3) 以随机、3 组阶梯式和 2 组设计评估这些干预措施,对于那些患有
计算机访问,(a) 第 1 组 = 对照组] 接收标准 CIS 服务和打印材料(NCI 的“面向前”
以及您需要了解的有关乳腺癌的信息); (b) 第 2 组 = 标准护理 + V-CIS; (c) 第 3 组 = 标准护理 +
V-CIS+2个CIS电话回拨;对于那些无法使用计算机的人,(d) 第 1 组 A=控制=相同标准
作为第 1 组打印; (e) 第 2A 组=标准打印 * 2 个 CIS 干预回调; (4) 评估理论驱动的测试
干预效果的中介因素(即自我效能、感知的应对技巧); (5) 测试假定的主持人(例如参与者
干预效果的年龄); (6)配合CIS,策划传播。为了测试干预措施的效果,研究人员对 1,800 名乳房进行了研究
CIS 的癌症呼叫者将被登记,并根据计算机访问情况,随机分为 3 组或 2 组
设计,并在基线后 2、6 和 12 个月进行随访。符合剂量反应梯度,主要
假设是第 3 组 > 第 2 组 > 第 i1 组(以及第 2A 组 > 第 1 A 组)
心理健康、身体健康、人际关系功能和生活观点等领域。关于的假设
干预措施如何(即调解员)以及对谁(即调解员)有效也将受到审查。项目3是
其独特之处在于它检查了最先进的软件程序和主动 CIS 发起的电话回叫,因此
解决 CIS 的主要服务使命。根据调查结果,CISRC 的目标是准备
独联体内部的传播干预以及全国范围内的其他服务计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Annette L Stanton其他文献
Annette L Stanton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Annette L Stanton', 18)}}的其他基金
Emotion Regulation and Depression in Breast Cancer Survivorship
乳腺癌幸存者的情绪调节和抑郁
- 批准号:
8587469 - 财政年份:2009
- 资助金额:
$ 12.48万 - 项目类别:
Emotion Regulation and Depression in Breast Cancer Survivorship
乳腺癌幸存者的情绪调节和抑郁
- 批准号:
8193240 - 财政年份:2009
- 资助金额:
$ 12.48万 - 项目类别:
Emotion Regulation and Depression in Breast Cancer Survivorship
乳腺癌幸存者的情绪调节和抑郁
- 批准号:
7736596 - 财政年份:2009
- 资助金额:
$ 12.48万 - 项目类别:
Emotion Regulation and Depression in Breast Cancer Survivorship
乳腺癌幸存者的情绪调节和抑郁
- 批准号:
7926904 - 财政年份:2009
- 资助金额:
$ 12.48万 - 项目类别:
Emotion Regulation and Depression in Breast Cancer Survivorship
乳腺癌幸存者的情绪调节和抑郁
- 批准号:
8462454 - 财政年份:2009
- 资助金额:
$ 12.48万 - 项目类别:
PREPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER
乳腺癌术后生活的准备性干预措施
- 批准号:
7172818 - 财政年份:2006
- 资助金额:
$ 12.48万 - 项目类别:
PREPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER
乳腺癌术后生活的准备性干预措施
- 批准号:
7726866 - 财政年份:
- 资助金额:
$ 12.48万 - 项目类别:
PREPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER
乳腺癌术后生活的准备性干预措施
- 批准号:
7917344 - 财政年份:
- 资助金额:
$ 12.48万 - 项目类别:
PREPARATORY INTERVENTIONS FOR LIFE AFTER BREAST CANCER
乳腺癌术后生活的准备性干预措施
- 批准号:
7726859 - 财政年份:
- 资助金额:
$ 12.48万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 12.48万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
- 批准号:
10736501 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别: